Literature DB >> 26269027

The Influence of Primary Cytomegalovirus or Epstein-Barr Virus Infection on the Course of Idiopathic Thrombocytopenic Purpura.

Katarzyna Smalisz-Skrzypczyk, Michał Romiszewski, Michał Matysiak, Urszula Demkow, Katarzyna Pawelec.   

Abstract

Idiopathic thrombocytopenic purpura (ITP) in children is usually triggered by a viral infections such as cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection. The aim of this study was to assess the frequency of CMV and EBV infections in children with first relapse of ITP, and the influence of these infections on the course and response to treatment of ITP. Sixty patients (30 boys and 30 girls) with ITP were enrolled into the study. We found that the age at the onset of ITP was from 1 month to 17 years (mean 7.0 ± 5.7 years), the platelet number was from 1 to 79 x 10(9)/L (mean 18.1 ± 19.0 x 10(9)/L) at the time of diagnosis and it increased from 17 to 395 x 10(9)/L (mean 134.4 ± 81.2 x 10(9)/L)(p < 0.05) after the first course of therapy. Forty seven patients required pharmacological treatment, the duration of the treatment was from 2 to 25 days (mean 6.1 ± 4.1 days). Relapses were observed in 27 (45%) of the patients. Active CMV infection was found in 19 patients (31.7%), EBV infection in 5 patients (8.3%), and both infections concomitantly in 1 patient (1.7%). The group of patients with CMV or EBV infection(n = 25) did not differ from the patients free of infection (n = 35) in regard to the age, number of platelets at onset, duration of treatment, number of platelets after treatment, number of relapses, and the interval between the onset and first relapse. In conclusion, active CMV or EBV infection is common in children with ITP. These infections do not seem to have an appreciable bearing on the clinical course and the response to treatment on children with ITP.

Entities:  

Mesh:

Year:  2016        PMID: 26269027     DOI: 10.1007/5584_2015_162

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.

Authors:  Rita Consolini; Giorgio Costagliola; Davide Spatafora
Journal:  Front Pediatr       Date:  2017-08-21       Impact factor: 3.418

2.  Analysis of clinical effects and mechanism of recombinant human interleukin-11 with glucocorticoids for treatment of idiopathic thrombocytopenic purpura.

Authors:  Xifeng Wu; Lijuan Wang; Lin Sun; Tantan Li; Xuehong Ran
Journal:  Exp Ther Med       Date:  2016-12-21       Impact factor: 2.447

3.  Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP).

Authors:  Farshad Abbasi; Gholam Abbas Kaydani; Zari Tahannezhad; Mohsen Nakhaie; Ali Amin Asnafi; Maryam Moradi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2021-07-01

4.  Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Authors:  Tao Li; Gui-Ling Yan; Zhu Luo; Qi Xie; Mei-Mei Lai; Zhan-Guo Chen; Xiao-Qun Zheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.